Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytek Biosciences (CTKB) Other financing activities (2021 - 2025)

Historic Other financing activities for Cytek Biosciences (CTKB) over the last 5 years, with Q3 2025 value amounting to $171000.0.

  • Cytek Biosciences' Other financing activities rose 1712.33% to $171000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $532000.0, marking a year-over-year increase of 114.07%. This contributed to the annual value of $554000.0 for FY2024, which is 3221.96% up from last year.
  • As of Q3 2025, Cytek Biosciences' Other financing activities stood at $171000.0, which was up 1712.33% from $102000.0 recorded in Q2 2025.
  • In the past 5 years, Cytek Biosciences' Other financing activities ranged from a high of $171000.0 in Q3 2025 and a low of -$1.1 million during Q3 2021
  • In the last 5 years, Cytek Biosciences' Other financing activities had a median value of $111000.0 in 2023 and averaged $33533.3.
  • Per our database at Business Quant, Cytek Biosciences' Other financing activities surged by 15964.91% in 2024 and then crashed by 2153.85% in 2025.
  • Quarter analysis of 5 years shows Cytek Biosciences' Other financing activities stood at -$1.1 million in 2021, then surged by 106.57% to $71000.0 in 2022, then skyrocketed by 43.66% to $102000.0 in 2023, then rose by 27.45% to $130000.0 in 2024, then soared by 31.54% to $171000.0 in 2025.
  • Its last three reported values are $171000.0 in Q3 2025, $102000.0 for Q2 2025, and $129000.0 during Q1 2025.